Proportion of participants with relapse‐free survival at ≥ 12 months
Intensive follow‐up showed no clear difference in relapse‐free survival compared with less intensive follow‐up (high certainty).
1 finding from 1 review
Salvage surgery (SS)
Intensive follow‐up leads to higher salvage surgery (surgery at relapse with curative intent) compared with less intensive follow‐up (high certainty).
1 finding from 1 review
Interval recurrences (IR)
Intensive follow‐up probably leads to lower interval recurrences (recurrence CRC diagnosed between scheduled compared with less intensive follow‐up (moderate certainty).
1 finding from 1 review
Harms Colonoscopy complications ‐ bowel perforation
It is very uncertain whether intensive follow‐up changes harms Colonoscopy complications ‐ bowel perforation compared with less intensive follow‐up (very low certainty).
1 finding from 1 review
Death (all causes) · non‐diabetic adults with CKD
Very low protein diet showed no clear difference in death (all causes) compared with low or normal protein diet (moderate certainty).
1 finding from 1 review
ESKD · non‐diabetic adults with CKD
Very low protein diet probably leads to lower ESKD compared with low or normal protein diet (moderate certainty).
1 finding from 1 review
End or change in GFR · non‐diabetic adults with CKD
1 finding from 1 review
Length of hospital stay · infants with bronchiolitis
1 finding from 1 review
Adverse events · infants with bronchiolitis
Summary of findings table ‐ High‐flow nasal cannula showed no clear difference in adverse events compared with standard oxygen therapy (low‐flow) (low certainty).
1 finding from 1 review
Change in respiratory rate at 20 minutes · infants with bronchiolitis
1 finding from 1 review
Change** in heart rate (beats/min) · infants with bronchiolitis
1 finding from 1 review
Need for treatment escalation · infants with bronchiolitis
Summary of findings table ‐ High‐flow nasal cannula probably leads to lower need for treatment escalation compared with standard oxygen therapy (low‐flow) (moderate certainty).
1 finding from 1 review
Duration of oxygen therapy (hours) · infants with bronchiolitis
1 finding from 1 review
Chronic lung disease · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of any form of respiratory support (any form of non‐invasive respiratory support with or without supplemental oxygen) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
ICU length of stay (selenium) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Length of hospital stay · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Adverse events · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Death · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Treatment failure · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
Summary of findings table ‐ High flow nasal cannula (HFNC) may leads to lower treatment failure compared with low flow nasal cannula (LFNC) (low certainty).
1 finding from 1 review